Trial Profile
A Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Different Doses of Larazotide Acetate for the Treatment of Celiac Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Jul 2020
Price :
$35
*
At a glance
- Drugs Larazotide (Primary)
- Indications Coeliac disease
- Focus Therapeutic Use
- Sponsors 9 Meters Biopharma [CEASED]; Alba Therapeutics
- 10 Oct 2015 New source identified and integrated. ClinicalTrials.gov
- 01 Oct 2014 New trial record